IL2 and inflammatory bowel disease: The fecal pro-inflammatory cytokines, such as IL-1β and IL-6, are increased in patients with active IBD, reflecting the mucosal inflammation, while IL-2 and IFNγ are down-regulated in the peripheral blood mononuclear cells of UC and CD patients [44,45].